Opportunity

The U.S. Food and Drug Administration (FDA) intends to award, on a sole source basis, a contract modification to increase the ceiling of the current Indefinite Delivery/Indefinite Quantity (IDIQ) bridge contract (Contract No. 75F40124D00066) with NVE, Inc., 13800 Coppermine Road, Suite 301, Herndon, VA 20171.

This modification will increase the total contract ceiling by $3.2M to ensure sufficient capacity for continued performance of 24/7 operations and maintenance (O&M) support services at the FDA-owned Muirkirk Road Complex (MRC) in Laurel, Maryland. The increase is required to cover essential mission-critical services during a four-month extension period while the agency completes the competitive acquisition process for a long-term follow-on contract.